Andrew Fraley

Co-founder & Chief Technology Officer

Andrew Fraley, Ph.D., co-founder and chief technology officer at Korro Bio, brings over 20 years of experience in the field of nucleic acid technologies and therapeutics.

Prior to Korro, Andrew was a co-founder of Triplet Therapeutics, and a founding executive team member serving as SVP of translational sciences for Trucode Gene Repair, an in v...

Roles at Korro Bio

  • Co-founder & Chief Technology Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.